Vietnam Veterinary Pharmaceuticals Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Vietnam veterinary pharmaceuticals market, valued at USD 1.1 Bn, is growing due to rising pet ownership, livestock demand, and government initiatives for animal health.

Region:Asia

Author(s):Rebecca

Product Code:KRAB2129

Pages:94

Published On:January 2026

About the Report

Base Year 2024

Vietnam Veterinary Pharmaceuticals Market Overview

  • The Vietnam Veterinary Pharmaceuticals Market is valued at USD 1.1 billion, based on a five-year historical analysis. This market is supported by Vietnam’s large and recovering livestock sector, rising demand for animal protein, and increasing investment in animal health, which collectively drive the use of veterinary drugs, vaccines, and medicated feed to improve productivity and prevent disease outbreaks.
  • Key regions driving the market include Ho Chi Minh City and Hanoi, which host a high concentration of pharmaceutical manufacturing, import–export facilities, wholesale networks, and veterinary service providers, supported by strong logistics and healthcare infrastructure. Other provinces with intensive livestock production clusters (particularly in the Mekong Delta and Red River Delta) also contribute significantly through commercial farms and contract production systems.
  • Veterinary pharmaceuticals in Vietnam are regulated under the Law on Animal Husbandry and the Law on Veterinary Medicine, operationalized through Decree No. 13/2020/ND-CP issued by the Government in 2020, which stipulates that veterinary drugs must be registered, assessed for quality, safety, and efficacy, and licensed by the Ministry of Agriculture and Rural Development before circulation.
Vietnam Veterinary Pharmaceuticals Market Size

Vietnam Veterinary Pharmaceuticals Market Segmentation

By Product Type:The product type segmentation includes various categories such as Veterinary Drugs, Vaccines, Medicated Feed Additives, Nutritional & Nutraceutical Products, Diagnostic & Supportive Therapeutics, and Others. Veterinary Drugs, particularly anti-infectives and anti-inflammatories, represent a major share of usage in livestock and companion animals due to the continued prevalence of infectious diseases and the need to manage productivity and welfare. Preventive healthcare through vaccines is increasingly emphasized in commercial farms as part of biosecurity strategies to control endemic and emerging animal diseases, while medicated feed additives and nutritional products are used to enhance growth performance, immunity, and feed efficiency.

Vietnam Veterinary Pharmaceuticals Market segmentation by Product Type.

By Route of Administration:The route of administration includes Oral, Parenteral (Injectable), Topical, and Others. The oral route is widely used in Vietnam’s livestock sector because it is suitable for mass treatment or prevention via feed and water, aligning with commercial poultry and swine production practices. Parenteral administration is essential for vaccines and high-value therapeutics that require precise dosing and rapid onset of action, particularly in companion animals and high-value breeding stock, while topical formulations are used for ectoparasite control and dermatological conditions in both farm and companion animals.

Vietnam Veterinary Pharmaceuticals Market segmentation by Route of Administration.

Vietnam Veterinary Pharmaceuticals Market Competitive Landscape

The Vietnam Veterinary Pharmaceuticals Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis, Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim, and Virbac contribute to innovation, geographic expansion, and service delivery in this space, often working through local subsidiaries and distribution partners to supply vaccines, anti-infectives, parasiticides, and specialty therapeutics.

Zoetis

1952

Parsippany, New Jersey, USA

Merck Animal Health

1891

Rahway, New Jersey, USA

Elanco Animal Health

1954

Greenfield, Indiana, USA

Boehringer Ingelheim

1885

Ingelheim am Rhein, Germany

Virbac

1968

Carros, France

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Vietnam Veterinary Pharmaceuticals Revenue (USD, Latest FY)

3-Year Revenue CAGR in Vietnam

Vietnam Market Share (%)

EBITDA Margin (%) – Vietnam Operations

R&D Spend as % of Revenue

Vietnam Veterinary Pharmaceuticals Market Industry Analysis

Growth Drivers

  • Increasing Pet Ownership:The pet population in Vietnam has surged to approximately 9 million, reflecting a growing trend in pet ownership. This increase is driven by urbanization and rising disposable incomes, with pet care spending projected to reach 1.6 trillion VND. As pet owners prioritize health and wellness, the demand for veterinary pharmaceuticals is expected to rise significantly, creating a robust market for pet health products and services.
  • Rising Demand for Livestock Health Products:Vietnam's livestock sector, which contributes around 4.6% to the national GDP, is experiencing heightened demand for health products. The livestock population is estimated at 31 million cattle and 41 million pigs. This growth is fueled by the need for improved productivity and disease management, leading to increased investments in veterinary pharmaceuticals to ensure livestock health and food safety.
  • Government Initiatives for Animal Health:The Vietnamese government has allocated approximately 600 billion VND for animal health initiatives, focusing on disease prevention and control. Policies promoting vaccination and biosecurity measures are being implemented to enhance livestock health. These initiatives not only support the veterinary pharmaceuticals market but also aim to improve food security and public health, driving further growth in the sector.

Market Challenges

  • Regulatory Compliance Issues:The veterinary pharmaceuticals market in Vietnam faces stringent regulatory requirements, with over 210 regulations governing drug approvals and usage. Compliance can be costly and time-consuming, often leading to delays in product launches. Companies must navigate complex bureaucratic processes, which can hinder innovation and market entry, particularly for smaller firms lacking resources to meet these demands.
  • High Competition Among Local and International Players:The Vietnamese veterinary pharmaceuticals market is characterized by intense competition, with over 110 local and international companies vying for market share. This competitive landscape drives down prices and pressures profit margins. Companies must differentiate their products through quality, innovation, and effective marketing strategies to maintain a competitive edge in this crowded market.

Vietnam Veterinary Pharmaceuticals Market Future Outlook

The Vietnam veterinary pharmaceuticals market is poised for significant growth, driven by increasing pet ownership and rising livestock health awareness. The trend towards organic and natural veterinary products is expected to gain momentum, reflecting consumer preferences for sustainable options. Additionally, advancements in digital veterinary services, including telemedicine, will enhance access to care. As the government continues to support animal health initiatives, the market will likely see increased investment and innovation, positioning it for a dynamic future.

Market Opportunities

  • Expansion of E-commerce for Veterinary Products:The rise of e-commerce in Vietnam presents a significant opportunity for veterinary pharmaceutical companies. With online sales projected to reach 220 billion VND, companies can leverage digital platforms to reach a broader customer base, particularly in urban areas where convenience is paramount. This shift can enhance product accessibility and drive sales growth.
  • Development of Innovative Veterinary Pharmaceuticals:There is a growing demand for innovative veterinary pharmaceuticals, particularly in areas such as vaccines and biologics. With the livestock sector's expansion, companies that invest in research and development can capitalize on this trend. The Vietnamese government’s support for innovation in agriculture further enhances the potential for breakthroughs in veterinary medicine, creating lucrative opportunities for market players.

Scope of the Report

SegmentSub-Segments
By Product Type

Veterinary Drugs (Anti-infectives, Anti-inflammatories, Others)

Vaccines

Medicated Feed Additives

Nutritional & Nutraceutical Products

Diagnostic & Supportive Therapeutics

Others

By Route of Administration

Oral

Parenteral (Injectable)

Topical

Others

By Animal Type

Livestock (Cattle, Swine, Poultry, Others)

Companion Animals

Aquaculture

Others

By Application

Disease Prevention (Prophylactic)

Treatment & Control (Therapeutic)

Productivity & Performance Enhancement

Others

By Distribution Channel

Veterinary Hospitals

Veterinary Clinics

Pharmacies & Drug Stores

Online Channels

Distributors / Wholesalers

Others

By Region

Northern Vietnam

Central Vietnam

Southern Vietnam

By Policy Support

Government Subsidies for Veterinary Products

Tax Incentives for Manufacturers

Research & Innovation Grants

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Agriculture and Rural Development, Ministry of Health)

Manufacturers and Producers

Distributors and Retailers

Veterinary Clinics and Hospitals

Animal Health NGOs and Advocacy Groups

Pharmaceutical Wholesalers

Trade Associations in Animal Health

Players Mentioned in the Report:

VetStem Biopharma

Regeneus

Aratana Therapeutics

Zoetis

Merck Animal Health

Elanco Animal Health

Boehringer Ingelheim

Vetoquinol

Virbac

Huvepharma

Phibro Animal Health

Neogen Corporation

IDEXX Laboratories

Alltech

Cegelec

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Vietnam Veterinary Pharmaceuticals Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Vietnam Veterinary Pharmaceuticals Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Vietnam Veterinary Pharmaceuticals Market Analysis

3.1 Growth Drivers

3.1.1 Increasing pet ownership
3.1.2 Rising demand for livestock health products
3.1.3 Government initiatives for animal health
3.1.4 Advancements in veterinary research and development

3.2 Market Challenges

3.2.1 Regulatory compliance issues
3.2.2 High competition among local and international players
3.2.3 Limited access to veterinary services in rural areas
3.2.4 Price sensitivity among consumers

3.3 Market Opportunities

3.3.1 Expansion of e-commerce for veterinary products
3.3.2 Increasing awareness of animal health
3.3.3 Development of innovative veterinary pharmaceuticals
3.3.4 Collaborations with agricultural sectors

3.4 Market Trends

3.4.1 Growth in organic and natural veterinary products
3.4.2 Digital transformation in veterinary services
3.4.3 Focus on preventive healthcare for animals
3.4.4 Rise in telemedicine for veterinary care

3.5 Government Regulation

3.5.1 Stricter regulations on veterinary drug approvals
3.5.2 Enhanced monitoring of veterinary pharmaceuticals
3.5.3 Policies promoting animal welfare
3.5.4 Import/export regulations for veterinary products

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Vietnam Veterinary Pharmaceuticals Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Vietnam Veterinary Pharmaceuticals Market Segmentation

8.1 By Product Type

8.1.1 Veterinary Drugs (Anti-infectives, Anti-inflammatories, Others)
8.1.2 Vaccines
8.1.3 Medicated Feed Additives
8.1.4 Nutritional & Nutraceutical Products
8.1.5 Diagnostic & Supportive Therapeutics
8.1.6 Others

8.2 By Route of Administration

8.2.1 Oral
8.2.2 Parenteral (Injectable)
8.2.3 Topical
8.2.4 Others

8.3 By Animal Type

8.3.1 Livestock (Cattle, Swine, Poultry, Others)
8.3.2 Companion Animals
8.3.3 Aquaculture
8.3.4 Others

8.4 By Application

8.4.1 Disease Prevention (Prophylactic)
8.4.2 Treatment & Control (Therapeutic)
8.4.3 Productivity & Performance Enhancement
8.4.4 Others

8.5 By Distribution Channel

8.5.1 Veterinary Hospitals
8.5.2 Veterinary Clinics
8.5.3 Pharmacies & Drug Stores
8.5.4 Online Channels
8.5.5 Distributors / Wholesalers
8.5.6 Others

8.6 By Region

8.6.1 Northern Vietnam
8.6.2 Central Vietnam
8.6.3 Southern Vietnam

8.7 By Policy Support

8.7.1 Government Subsidies for Veterinary Products
8.7.2 Tax Incentives for Manufacturers
8.7.3 Research & Innovation Grants
8.7.4 Others

9. Vietnam Veterinary Pharmaceuticals Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Vietnam Veterinary Pharmaceuticals Revenue (USD, Latest FY)
9.2.4 3-Year Revenue CAGR in Vietnam
9.2.5 Vietnam Market Share (%)
9.2.6 EBITDA Margin (%) – Vietnam Operations
9.2.7 R&D Spend as % of Revenue
9.2.8 Product Portfolio Breadth (Number of SKUs / Therapeutic Classes)
9.2.9 Average Realized Price vs Market Average
9.2.10 Distribution Reach (Provinces / Active Accounts)
9.2.11 Key Account Concentration (% of Revenue from Top 10 Customers)
9.2.12 Regulatory Compliance Track Record (Approvals / Warnings)
9.2.13 Brand Awareness / Preference Score (Survey-Based)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 VetStem Biopharma
9.5.2 Regeneus
9.5.3 Aratana Therapeutics
9.5.4 Zoetis
9.5.5 Merck Animal Health
9.5.6 Elanco Animal Health
9.5.7 Boehringer Ingelheim
9.5.8 Vetoquinol
9.5.9 Virbac
9.5.10 Huvepharma
9.5.11 Phibro Animal Health
9.5.12 Neogen Corporation
9.5.13 IDEXX Laboratories
9.5.14 Alltech
9.5.15 Cegelec

10. Vietnam Veterinary Pharmaceuticals Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget allocation for veterinary health
10.1.2 Decision-making processes
10.1.3 Supplier selection criteria
10.1.4 Contract management practices

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in veterinary facilities
10.2.2 Spending on veterinary training programs
10.2.3 Budget for veterinary pharmaceuticals

10.3 Pain Point Analysis by End-User Category

10.3.1 Access to quality veterinary care
10.3.2 Affordability of veterinary products
10.3.3 Availability of veterinary services

10.4 User Readiness for Adoption

10.4.1 Awareness of veterinary health products
10.4.2 Training and education needs

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Evaluation of veterinary product effectiveness
10.5.2 Expansion into new animal health markets

11. Vietnam Veterinary Pharmaceuticals Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban retail vs rural NGO tie-ups


4. Channel & Pricing Gaps

4.1 Underserved routes

4.2 Pricing bands


5. Unmet Demand & Latent Needs

5.1 Category gaps

5.2 Consumer segments


6. Customer Relationship

6.1 Loyalty programs

6.2 After-sales service


7. Value Proposition

7.1 Sustainability

7.2 Integrated supply chains


8. Key Activities

8.1 Regulatory compliance

8.2 Branding

8.3 Distribution setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product mix
9.1.2 Pricing band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target countries
9.2.2 Compliance roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven analysis

13.2 Long-term sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone tracking
15.2.2 Activity scheduling

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from veterinary pharmaceutical associations in Vietnam
  • Review of government publications and regulatory frameworks affecting veterinary pharmaceuticals
  • Examination of market trends and statistics from international organizations such as the FAO and OIE

Primary Research

  • Interviews with veterinarians and veterinary pharmacists to understand product usage and preferences
  • Surveys with livestock farmers to gauge demand for veterinary products and services
  • Focus group discussions with industry stakeholders, including distributors and retailers

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including trade publications and expert opinions
  • Triangulation of market data with sales figures from leading veterinary pharmaceutical companies
  • Sanity checks through expert panel reviews comprising veterinarians and industry analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total market size based on national livestock population and veterinary product usage rates
  • Segmentation of the market by product type, including vaccines, antibiotics, and antiparasitics
  • Incorporation of growth rates from historical data and projected livestock industry trends

Bottom-up Modeling

  • Collection of sales data from key veterinary pharmaceutical distributors and manufacturers
  • Estimation of average pricing for various veterinary products across different regions
  • Volume estimates based on livestock health management practices and treatment frequency

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating factors such as livestock population growth and disease outbreaks
  • Scenario modeling based on potential regulatory changes and shifts in consumer preferences
  • Development of baseline, optimistic, and pessimistic market forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Veterinary Clinics90Veterinarians, Clinic Managers
Livestock Farmers120Farm Owners, Livestock Managers
Pharmaceutical Distributors70Sales Managers, Distribution Coordinators
Regulatory Bodies40Policy Makers, Regulatory Affairs Specialists
Research Institutions60Researchers, Veterinary Scientists

Frequently Asked Questions

What is the current value of the Vietnam Veterinary Pharmaceuticals Market?

The Vietnam Veterinary Pharmaceuticals Market is valued at approximately USD 1.1 billion, driven by a recovering livestock sector, increasing demand for animal protein, and rising investments in animal health.

What are the key regions contributing to the Vietnam Veterinary Pharmaceuticals Market?

What regulations govern veterinary pharmaceuticals in Vietnam?

What are the main product types in the Vietnam Veterinary Pharmaceuticals Market?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022